Behandlung von Ewing-Sarkom in Israel — erhalten Sie 3 personalisierte Klinikempfehlungen

Israeli medical centers report a 5-year survival rate of 82% for localized Ewing sarcoma. Success depends on the disease stage and treatment protocols. Specialized oncology centers in Tel Aviv and Jerusalem achieve complete remission in 70% of treated cases.

• Localized survival: Rates reach up to 82% for patients with localized disease.
• Regional spread: Five-year survival is approximately 71% when nearby tissues are involved.
• Metastatic cases: Survival typically ranges between 15% and 39% for distant spread.
• Remission success: Israeli oncology centers report 70% complete remission after multimodal treatment.

Bookimed Expert Insight: Israeli oncology excellence is driven by multidisciplinary expertise at centers like Sourasky, which reports a 90% average success rate. Dr. Ofer Merimsky leads specialized bone sarcoma units there. High-volume centers often combine surgery with bone marrow transplants for pediatric cases to improve outcomes.

Patient Consensus: Patients emphasize that while public statistics are rare, Israeli multidisciplinary teams provide high confidence. They recommend comparing local protocols with international standards during initial oncology consultations.

Leading Israeli hospitals specializing in Ewing s sarcoma include Sheba Medical Center, Sourasky Medical Center, and Rambam Medical Center. These facilities typically hold Joint Commission International (JCI) accreditation. Specialized centers use precision medicine and multidisciplinary teams to treat complex bone and soft tissue tumors.

• Accreditation standards: Most major centers maintain JCI and ISO certifications for safety.
• Specialized units: Sourasky hosts the National Center for bone and soft tissues sarcomas.
• Pediatric expertise: Sheba offers specific pediatric bone marrow transplant programs for high-risk cases.
• Global rankings: Sheba and Sourasky are consistently ranked among the world's best hospitals.

Bookimed Expert Insight: While Sheba Medical Center is globally ranked 7th for 2026, Sourasky reports a 90% oncology success rate. Patients seeking pediatric care should note that Dr. Hana Golan at Sheba and Dr. Dror Levin at Sourasky specialize specifically in pediatric sarcoma coordination. Comparing these centers is vital as Sourasky serves 400,000 patients annually while Sheba handles over 2 million, indicating different scales of resource accessibility.

Patient Consensus: Patients often emphasize the coordinated care between orthopedists and oncologists. Many note it is helpful to have a dedicated coordinator for complex pediatric treatment schedules.

Israeli oncology centers provide multi-modal treatment including high-dose chemotherapy, limb-sparing surgery, and bone marrow transplantation. Facilities like Sheba Medical Center utilize PET/CT imaging and molecular profiling to tailor protocols. Specialized units focus on pediatric cases using advanced techniques like stem cell rescue and CAR-T therapies.

• Surgical precision: Surgeons perform complex limb-sparing resections to preserve functional movement and outcomes.
• Advanced diagnostics: PET/CT imaging and genetic profiling identify EWSR1-FLI1 fusions for targeted therapy.
• Cellular therapy: Bone marrow transplantation is offered for pediatric high-risk or recurrent sarcoma cases.
• Expert consultation: Multidisciplinary teams include oncologists, radiologists, and orthopedic surgeons for integrated care.

Bookimed Expert Insight: While chemotherapy remains the standard, clinics like Sheba and Sourasky differentiate through volume and specialization. Dr. Boaz Liberman at Sheba focuses on functional outcomes using magnetic resonance-guided ultrasound. Sourasky reports a 90% oncology success rate with experts like Dr. Ofer Merimsky. These centers manage high patient volumes, often treating over 1,000,000 people annually.

Patient Consensus: Patients note that Israel offers faster access to experimental treatments and compassionate use drugs compared to many global waitlists. Families emphasize the importance of early genetic testing to ensure eligibility for the newest clinical trials and targeted therapies.

Ewing's sarcoma treatment in Israel typically requires a stay of 30 days for advanced procedures like bone marrow transplants. Diagnostics usually take 3 to 4 days. Complex therapy cycles or cellular treatments often extend the residency to 21 days or more for safe monitoring.

• Diagnostic phase: Initial PET/CT, biopsies, and blood tests usually require 3 to 4 days.
• Transplant recovery: Pediatric bone marrow transplant packages include 30 days of hospital room stay.
• Cellular therapy: Advanced oncology treatments like CAR-T therapy necessitate roughly 21 days of monitoring.
• Surgical stays: Post-operative observation periods vary based on the complexity of the bone lesion removal.

Bookimed Expert Insight: While a 30-day stay is standard for complex transplants at centers like Sheba Medical Center, patients should focus on the package inclusions. Most high-tier Israeli packages already bundle 24-hour nursing and nutritionist-led meals into that month-long stay. This significantly reduces the logistical burden during such an intensive recovery period.

Patient Consensus: Patients note it is helpful to have all-inclusive transfers and meals bundled. They often mention the peace of mind provided by having 24-hour nursing care during long hospital stays.

Follow-up surveillance for Ewing's sarcoma involves a strict schedule of imaging and blood tests to monitor for recurrence. Patients typically undergo PET-CT scans, chest X-rays, and local site imaging every three months for the first two years. These protocols ensure early detection. Israel's oncology centers provide detailed home-transition plans.

• Imaging frequency: Scans occur every 3–6 months during the initial surveillance years.
• Diagnostic methods: Monitoring includes PET-CT, localized CT scans, and scintigraphy for bone health.
• Blood monitoring: Regular complete blood counts and tumor marker analysis track systemic recovery.
• Lung surveillance: Routine chest CTs are standard to check for pulmonary metastasis.

Bookimed Expert Insight: While major centers like Sheba Medical Center handle over 2 million patients yearly, the follow-up for Ewing's sarcoma is highly personalized based on the initial tumor location. For example, Dr. Iris Kventsel at Sheba specializes in pediatric bone marrow transplants, where follow-up often includes computerized bone mineralometry for long-term skeletal health. Patients should ensure their discharge papers explicitly link their surgeons and onco-hematologists for coordinated imaging reviews.

Patient Consensus: Patients emphasize the need to request a written two-to-five year surveillance schedule before leaving Israel. Many note that maintaining a personal log of scan dates is vital because coordination between different departments can vary.

Limb-salvage surgery is possible in approximately 90% of oncology cases in Israel. Surgeons prioritize saving the limb unless the tumor involves major nerves or blood vessels. Amputation is necessary only if tumor removal would result in a non-functional extremity or risk life.

• Surgical feasibility: Surgeons at Sourasky Medical Center maintain a 90% oncology success rate.
• Treatment options: Available techniques include limb-sparing surgery, reconstruction, and magnetic resonance-guided focused ultrasound.
• Specialized expertise: Dr. Boaz Liberman at Sheba specializes in complex reconstruction and limb-sparing.
• Pediatric solutions: Bone marrow transplantation is used for pediatric Ewing sarcoma at Sheba.

Bookimed Expert Insight: Israeli specialists like Dr. Boaz Liberman often use high-volume training from Canadian and US centers to perform complex skeletal reconstructions. Sheba Medical Center uniquely offers MRgFUS technology. This allows for non-invasive treatment of certain bone lesions. This technology can preserve bone integrity before considering invasive surgery. This combination of precision imaging and surgical experience often shifts the decision toward salvage.

Patient Consensus: Patients note that pelvic Ewing sarcoma may still require amputation if nerves are involved. Many emphasize that a functional prosthesis can sometimes offer better mobility than a salvaged limb with chronic pain.

Patients traveling to Israel for Ewing's sarcoma treatment require a valid passport and often a B2 medical visa. Advanced medical preparations include translating previous scans and reports into English. Pre-arrival pathology reviews and teleconsultations with oncologists help confirm treatment readiness and avoid unnecessary delays upon landing.

• Travel visa: Apply for a B2 medical visa via an Israeli embassy for extended stays.
• Medical records: Translate all pathology reports and PET/CT scans into English or Hebrew.
• Vaccination status: Ensure routine shots like Flu and MMR are current before starting chemotherapy.
• Financial planning: Budget for document translation services which may cost $500 to $1,000.

Bookimed Expert Insight: Israeli oncology centers like Sheba Medical Center often require highly specific diagnostic benchmarks. Our data shows that top centers include comprehensive pre-transplant screenings in their packages. While some packages like Sheba's $160,000 bone marrow transplant include full diagnostics, patients should still send baseline bloodwork early. This allows the Israeli team to adjust protocols before you even board the plane.

Patient Consensus: Patients note it is vital to ship medical records ahead of time to prevent intake delays. They also emphasize that a pre-travel teleconsultation is essential for securing a treatment slot.